NALLPEN IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Nallpen In Plastic Container patents expire, and what generic alternatives are available?
Nallpen In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in NALLPEN IN PLASTIC CONTAINER is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nallpen In Plastic Container
A generic version of NALLPEN IN PLASTIC CONTAINER was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NALLPEN IN PLASTIC CONTAINER?
- What are the global sales for NALLPEN IN PLASTIC CONTAINER?
- What is Average Wholesale Price for NALLPEN IN PLASTIC CONTAINER?
Summary for NALLPEN IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Patent Applications: | 1,541 |
| DailyMed Link: | NALLPEN IN PLASTIC CONTAINER at DailyMed |
Pharmacology for NALLPEN IN PLASTIC CONTAINER
| Drug Class | Penicillin-class Antibacterial |
US Patents and Regulatory Information for NALLPEN IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | NALLPEN IN PLASTIC CONTAINER | nafcillin sodium | INJECTABLE;INJECTION | 050655-002 | Oct 31, 1989 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | NALLPEN IN PLASTIC CONTAINER | nafcillin sodium | INJECTABLE;INJECTION | 050655-001 | Oct 31, 1989 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
